R590-287-3. Definitions

Terms used in this rule are defined in Sections 31A-1-301 and 31A-48-102. Additional terms are defined as follows: (1) "Drug product" means the finished dosage form of a drug that contains a drug substance, in association with other active or inactive ingredients, and that has a unique NDC. (2) "FDA" means the United States Food and Drug Administration. (3) "National Drug Code" or "NDC" means a three-segment code maintained by the FDA that is converted to an 11-digit format and includes a: (a) labeler code; (b) product code; and (c) package code. (4) "WAC" means wholesale acquisition cost.